Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Aug 28, 2025

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
09:58

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma

Published on: June 6, 2025

412

Single-Nucleotide Polymorphism Array for Histologically Ambiguous Melanocytic Tumors.

Katherine B Geiersbach1, Troy J Gliem2, Sarah M Jenkins3

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

The Journal of Molecular Diagnostics : JMD
|September 17, 2022
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Haematologica·2026
Same author

A report of thirteen non-conventional FLCN-mutated (renal) tumors (FMT) and a discussion of proposed diagnostic criteria, convergent FLCN/TFEB and FLCN/MITF E318K signaling, and FLCN immunohistochemistry.

Human pathology·2026
Same author

DICER1 Syndrome-Associated Thyroid Follicular Nodular Disease.

Mayo Clinic proceedings·2026
Same author

DDX5::TFEB-Rearranged Melanotic PEComa.

Mayo Clinic proceedings·2026
Same author

Xanthogranulomatous Epithelial Tumor/Keratin-Positive Giant Cell-Rich Soft Tissue Tumor.

Mayo Clinic proceedings·2026
Same author

Insights into clonal and complete blood count changes at disease evolution among patients with clonal cytopenia of undetermined significance.

Haematologica·2026
This summary is machine-generated.

Single-nucleotide polymorphism (SNP) array analysis reveals that the number of copy number abnormalities effectively distinguishes benign from malignant melanocytic tumors. This method aids in diagnosing ambiguous cases, offering intermediate profiles for uncertain melanocytic neoplasms.

Area of Science:

  • Oncology
  • Genetics
  • Dermatopathology

Background:

  • Single-nucleotide polymorphism (SNP) array analysis is a valuable tool in diagnosing melanocytic tumors.
  • Histologically ambiguous melanocytic tumors present diagnostic challenges.
  • Copy number abnormalities are increasingly recognized as key indicators in tumor profiling.

Purpose of the Study:

  • To evaluate the utility of genome-wide copy number profiling using SNP arrays in the diagnostic workup of melanocytic tumors.
  • To identify specific copy number abnormalities associated with malignancy in melanocytic neoplasms.
  • To assess the diagnostic performance of SNP arrays in distinguishing benign from malignant melanocytic tumors, especially in ambiguous cases.

Main Methods:

  • Analysis of genome-wide copy number profiling data from 675 melanocytic tumors using SNP arrays.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.2K

Related Experiment Videos

Last Updated: Aug 28, 2025

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
09:58

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma

Published on: June 6, 2025

412
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.2K
  • Comparison of SNP array results between histologically ambiguous tumors, benign nevi, and malignant melanomas.
  • Statistical analysis to determine the association between copy number abnormalities and malignancy.

    • Main Results:

    • The total number of somatic copy number abnormalities, sub-chromosomal abnormalities, regions of homozygosity, and abnormalities in disease-associated regions were significantly associated with malignancy.
    • The number of copy number abnormalities was the strongest discriminator between benign and malignant melanocytic diagnoses.
    • Histologically ambiguous tumors exhibited an intermediate spectrum of abnormalities, including 11p gains, copy state transitions over kinase genes, and 3p deletions overlapping BAP1 in Spitzoid neoplasms.

    Conclusions:

    • SNP array analysis is a powerful method for differentiating benign from malignant melanocytic tumors.
    • The number of copy number abnormalities serves as a key metric for malignancy assessment.
    • Integrated diagnostic approaches incorporating SNP array data are crucial for accurate interpretation, particularly in challenging cases of histologically ambiguous melanocytic neoplasms.